Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 69,242 |
|
|||||
| News | - | ||||||
| Day High | 2.66 | Low High |
|||||
| Day Low | 2.54 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Panacea Acquisition Corp | NUVB | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.105 | -3.95% | 2.555 | 09:50:30 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.64 | 2.54 | 2.66 | 2.66 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 384 | 69,242 | $ 2.59 | $ 179,437 | - | 0.95 - 4.1598 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:50:30 | 100 | $ 2.555 | USD |
Panacea Acquisition Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 582.66M | 219.05M | - | 0 | -75.8M | -0.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Panacea Acquisition News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NUVB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.65 | 2.79 | 2.505 | 2.64 | 1,181,989 | -0.095 | -3.58% |
| 1 Month | 4.03 | 4.1598 | 2.505 | 3.21 | 1,563,510 | -1.48 | -36.60% |
| 3 Months | 1.65 | 4.1598 | 1.52 | 2.82 | 1,384,242 | 0.905 | 54.85% |
| 6 Months | 1.18 | 4.1598 | 0.95 | 2.00 | 1,360,783 | 1.38 | 116.53% |
| 1 Year | 1.75 | 4.1598 | 0.95 | 1.87 | 961,247 | 0.805 | 46.00% |
| 3 Years | 11.25 | 15.23 | 0.95 | 4.30 | 874,385 | -8.70 | -77.29% |
| 5 Years | 10.00 | 15.23 | 0.95 | 4.85 | 882,048 | -7.45 | -74.45% |
Panacea Acquisition Description
| Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. |
